Are the latest drugs fit for purpose in MAPK/ERK and PI3K signalling pathways?

Date 21 December 2015
Event ESMO Asia 2015 Congress
Session Translating emerging therapeutics into clinical use
Topics Anti-Cancer Agents & Biologic Therapy
Gastrointestinal Cancers
Translational Research
Presenter Fortunato Ciardiello
Authors F. Ciardiello
  • Second University of Naples, 80131 - Naples/IT